Imperfect vision is a common problem around the world. It's the basis for large businesses at Essilor (NASDAQOTH: ESLOY ) , Hoya, and Luxottica (NYSE: LUX ) , as well as contact-lens manufacturers like Johnson & Johnson (NYSE: JNJ ) , Novartis, Cooper (NYSE: COO ) , and Valeant (NYSE: VRX )
. Not only is providing vision care products a profitable business in
its own right, which often supports double-digit returns on capital, it
is a business where customers typically have to buy the product over and
over again throughout their life. Add in above-average growth prospects
from emerging markets and it is not too difficult to see why these
businesses generally carry robust valuations.
Follow this link for the full article:
Is There Opportunity in the Eye-Care Sector?
No comments:
Post a Comment